Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism

NCT01847196 is registered in ClinicalTrials.gov with BiO2 Medical as lead sponsor.

NCT NCT01847196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01847196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
Lead sponsor
BiO2 Medical
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2013
Completion date
June 30, 2014
Enrollment
6 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism, venous thromboembolism